FINWIRES · TerminalLIVE
FINWIRES

$MRVI

4 stories mentioning MRVIUpdated just now

Every FINWIRES story that references MRVI, newest first.

Sectors

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index decreasing 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.4%.The iShares Biotechnology ETF (IBB) fell 2.4%.In corporate news, Merck's (MRK) strong momentum continues, driven by better-than-expected cancer vaccine data, but valuation now fully reflects the upside, RBC Capital Markets said in a note. RBC downgraded Merck to sector perform from outperform, and raised its price target to $150 from $142. Merck shares were down 1.9%.Moderna (MRNA) shares fell past 24% following a 177% jump at the close of the previous trading session. The drugmaker and Merck announced positive topline results from a late-stage trial of an experimental skin cancer treatment on Wednesday.Maravai LifeSciences (MRVI) stock rallied alongside a sector-wide rise in mRNA and oncology-focused biotech stocks. Maravai shares jumped 14%.Vivos Therapeutics (VVOS) said Thursday it has opened a new facility in Henderson, Nevada, to meet growing demand for sleep apnea testing and treatment. Vivos shares added 0.8%.

$MRK$MRNA$MRVI$VVOS
Wire

Top Midday Gainers

Xos (XOS) shares were up roughly 30% Thursday after the company said late Wednesday its mobile and stationary energy storage system received the UL 2202 safety certification administered by UL Solutions for electric vehicle direct-current charging equipment. A day earlier the company signed a US Air Force prototype agreement to develop for mobile charging for electric support vehicles.Intraday trading volume catapulted to over 12.7 million shares from a daily average of around 5.1 million.ScanSource (SCSC) reported higher fiscal Q4 non-GAAP net income and net sales.Shares rose nearly 18%, with intraday trading volume at over 656,000 against a daily average of roughly 223,000.Maravai LifeSciences (MRVI) stock rallied alongside a sector-wide rise in mRNA and oncology-focused biotech stocks.Shares increased past 12% as intraday trading volume soared to over 8.6 million from a daily average of roughly 3 million shares.Price: $3.76, Change: $+0.86, Percent Change: +29.52%

$MRVI$SCSC$XOS
Wire

Maravai Lifesciences Unit TriLink Opens Enzyme Manufacturing Facility in Florida

Maravai Lifesciences (MRVI) unit TriLink said Tuesday it has opened its Good Manufacturing Practice enzyme manufacturing facility in Jupiter, Florida.The facility supports a coordinated supply of key RNA manufacturing and In Vitro Transcription workflow materials from early research through commercial production, the company said.It is designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently, according to a statement.Price: $5.02, Change: $+0.06, Percent Change: +1.21%

$MRVI
Insider Trading

Maravai Lifesciences Holdings Insider Sold Shares Worth $254,000, According to a Recent SEC Filing

Kurt Oreshack, General Counsel, on June 09, 2026, sold 50,000 shares in Maravai Lifesciences Holdings (MRVI) for $254,000. Following the Form 4 filing with the SEC, Oreshack has control over a total of 335,767 Class A common shares of the company, with 335,767 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1823239/000183257926000007/xslF345X05/wk-form4_1781125600.xml

$MRVI

Track with the FINWIRES app suite